You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Treanda

Showing 1 - 25 of 117
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Classical Hodgkin Lymphoma, Relapsed Cancer, Refractory Cancer Trial in Toronto (Pembrolizumab, Bendamustine Hydrochloride)

Recruiting
  • Classical Hodgkin Lymphoma
  • +2 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Dec 31, 2021

Diffuse Large B Cell Lymphoma, Transformed Indolent Non-Hodgkin's Lymphoma, Follicular Lymphoma Trial (FT596, Cyclophosphamide,

Withdrawn
  • Diffuse Large B Cell Lymphoma
  • +4 more
  • (no location specified)
Jun 28, 2023

Multiple Myeloma Trial in Saint Louis (Isatuximab, Bendamustine, Prednisone)

Recruiting
  • Multiple Myeloma
  • Isatuximab
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Sep 21, 2022

Follicular Lymphoma Trial (Bendamustine, Rituximab, Tazemetostat)

Not yet recruiting
  • Follicular Lymphoma
  • (no location specified)
Dec 15, 2022

Follicular Lymphoma (FL) Trial in Westbury (Odronextamab, Rituximab, Cyclophosphamide)

Recruiting
  • Follicular Lymphoma (FL)
  • Westbury, New York
    Clinical Research Alliance Inc
Oct 13, 2023

Multiple Myeloma, CLL, Chronic Lymphocytic Leukemia Trial in Los Angeles (radiation, procedure, biological, drug)

Active, not recruiting
  • Multiple Myeloma
  • +4 more
  • Total Body Irradiation
  • +5 more
  • Los Angeles, California
    Cedars Sinai Medical Center
Dec 21, 2022

Lymphoma, Lymphoma, B-Cell, Immune System Diseases Trial in Chapel Hill (iC9-CAR19 T cells, Bendamustine, Fludarabine)

Recruiting
  • Lymphoma
  • +4 more
  • iC9-CAR19 T cells
  • +4 more
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center at University of North Ca
Dec 2, 2022

Mantle Cell Lymphoma Trial (parsaclisib, rituximab, bendamustine)

Withdrawn
  • Mantle Cell Lymphoma
  • (no location specified)
Apr 22, 2022

Waldenstrom Macroglobulinemia Trial in Canada (Acalabrutinib, Bendamustine, Rituximab)

Recruiting
  • Waldenstrom Macroglobulinemia
  • Calgary, Alberta, Canada
  • +8 more
Nov 9, 2022

Hodgkin Lymphoma, Adult Trial in Chapel Hill (ATLCAR.CD30, Bendamustine, Fludarabine)

No longer available
  • Hodgkin Lymphoma, Adult
  • ATLCAR.CD30
  • +2 more
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center at University of North Ca
Dec 2, 2021

Non-Hodgkin's Lymphoma Trial in Philadelphia (drug, procedure, genetic)

Completed
Has Results
  • Non-Hodgkin's Lymphoma
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Sep 14, 2022

Mantle Cell Lymphoma Trial in Saint Louis (Bendamustine, Rituximab, Acalabrutinib)

Active, not recruiting
Has Results
  • Mantle Cell Lymphoma
  • Saint Louis, Missouri
    Washington University School of Medicine
Feb 2, 2022

AL Amyloidosis Trial in New York (Venetoclax Oral Tablet, 200 mg, FISH assay, Venetoclax Oral Tablet, 400 mg)

Not yet recruiting
  • AL Amyloidosis
  • Venetoclax Oral Tablet, 200 mg
  • +9 more
  • New York, New York
    New York Presbyterian Hospital/Columbia University Irving Medica
Jul 11, 2022

Classical Hodgkin Lymphoma, Hodgkin Disease Refractory, Hodgkin Disease Recurrent Trial in United States (Nivolumab, Autologous

Recruiting
  • Classical Hodgkin Lymphoma
  • +2 more
  • Duarte, California
  • +4 more
Jun 27, 2022

Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin

Completed
Has Results
  • Adult Lymphocyte Depletion Hodgkin Lymphoma
  • +5 more
  • gemcitabine hydrochloride
  • bendamustine hydrochloride
  • Atlanta, Georgia
  • +1 more
Oct 21, 2021

Recurrent Follicular Lymphoma, Refractory Follicular Lymphoma Trial in Sacramento (Bendamustine Hydrochloride, Brentuximab

Recruiting
  • Recurrent Follicular Lymphoma
  • Refractory Follicular Lymphoma
  • Bendamustine Hydrochloride
  • Brentuximab Vedotin
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Dec 17, 2021

Relapsed T-Cell Lymphoma, Refractory T-Cell Lymphoma, Non Hodgkin Lymphoma Trial in Winston-Salem (CPI 613, Bendamustine)

Recruiting
  • Relapsed T-Cell Lymphoma
  • +2 more
  • Winston-Salem, North Carolina
    Wake Forest Baptist Comprehensive Cancer Center
Aug 27, 2021

Mantle Cell Lymphoma Trial in Boston (Rituximab, Bendamustine, Cytarabine)

Active, not recruiting
Has Results
  • Mantle Cell Lymphoma
  • Boston, Massachusetts
  • +2 more
Jun 9, 2021

Recurrent Hodgkin Lymphoma, Refractory Hodgkin Lymphoma, Classical Hodgkin Lymphoma Trial in Atlanta (Bendamustine, Gemcitabine,

Active, not recruiting
  • Recurrent Hodgkin Lymphoma
  • +3 more
  • Atlanta, Georgia
  • +1 more
Aug 25, 2021

Multiple Myeloma Trial in Milwaukee (MLN9708, Dexamethasone, Bendamustine (multiple dose levels))

Completed
Has Results
  • Multiple Myeloma
  • Milwaukee, Wisconsin
    Froedtert Hospital and the Medical College of Wisconsin
Sep 30, 2020

MALT, Nodal Marginal Zone B-cell Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma Trial in Columbus (drug, biological,

Active, not recruiting
  • Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
  • +9 more
  • BTK inhibitor PCI-32765
  • +5 more
  • Columbus, Ohio
    Ohio State University Medical Center
Jun 27, 2022

Mantle Cell Lymphoma, Follicular Lymphoma, Splenic Marginal Zone Lymphoma Trial in Chapel Hill (CAR.k.28, Fludarabine,

Recruiting
  • Mantle Cell Lymphoma
  • +5 more
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center at University of North Ca
Nov 19, 2021

Lymphoma, Non-Hodgkin, Lymphoma, Follicular, Lymphoma, Mantle-Cell Trial in Providence (Rituximab, Bendamustine, Vincristine

Active, not recruiting
  • Lymphoma, Non-Hodgkin
  • +5 more
  • Providence, Rhode Island
    Rhode Island Hospital and The Miriam Hospital
Jul 19, 2021

Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma Trial in New York (Bendamustine, Carmustine, Etoposide)

Completed
Has Results
  • Hodgkin's Lymphoma
  • Non-Hodgkin's Lymphoma
  • New York, New York
    Weill Cornell Medical College
Feb 1, 2021

Lymphoma, Non-Hodgkin, Lymphoma Trial in Davis, San Diego, San Francisco (Carfilzomib, Bendamustine, Rituximab)

Completed
  • Lymphoma, Non-Hodgkin
  • Lymphoma
  • Davis, California
  • +2 more
Apr 21, 2021